218 related articles for article (PubMed ID: 33160377)
1. Superparamagnetic iron oxide nanoparticles conjugated with Aβ oligomer-specific scFv antibody and class A scavenger receptor activator show therapeutic potentials for Alzheimer's Disease.
Liu XG; Zhang L; Lu S; Liu DQ; Huang YR; Zhu J; Zhou WW; Yu XL; Liu RT
J Nanobiotechnology; 2020 Nov; 18(1):160. PubMed ID: 33160377
[TBL] [Abstract][Full Text] [Related]
2. Multifunctional Superparamagnetic Iron Oxide Nanoparticles Conjugated with Aβ Oligomer-Specific scFv Antibody and Class A Scavenger Receptor Activator Show Early Diagnostic Potentials for Alzheimer's Disease.
Liu XG; Zhang L; Lu S; Liu DQ; Zhang LX; Yu XL; Liu RT
Int J Nanomedicine; 2020; 15():4919-4932. PubMed ID: 32764925
[TBL] [Abstract][Full Text] [Related]
3. Pan-amyloid oligomer specific scFv antibody attenuates memory deficits and brain amyloid burden in mice with Alzheimer's disease.
Zhao M; Wang SW; Wang YJ; Zhang R; Li YN; Su YJ; Zhou WW; Yu XL; Liu RT
Curr Alzheimer Res; 2014 Jan; 11(1):69-78. PubMed ID: 24156260
[TBL] [Abstract][Full Text] [Related]
4. A multifunctional peptide rescues memory deficits in Alzheimer's disease transgenic mice by inhibiting Aβ42-induced cytotoxicity and increasing microglial phagocytosis.
Xue D; Zhao M; Wang YJ; Wang L; Yang Y; Wang SW; Zhang R; Zhao Y; Liu RT
Neurobiol Dis; 2012 Jun; 46(3):701-9. PubMed ID: 22426388
[TBL] [Abstract][Full Text] [Related]
5. Activated scavenger receptor A promotes glial internalization of aβ.
Zhang H; Su YJ; Zhou WW; Wang SW; Xu PX; Yu XL; Liu RT
PLoS One; 2014; 9(4):e94197. PubMed ID: 24718459
[TBL] [Abstract][Full Text] [Related]
6. ScFv-conjugated superparamagnetic iron oxide nanoparticles for MRI-based diagnosis in transgenic mouse models of Parkinson's and Huntington's diseases.
Liu XG; Lu S; Liu DQ; Zhang L; Zhang LX; Yu XL; Liu RT
Brain Res; 2019 Mar; 1707():141-153. PubMed ID: 30481502
[TBL] [Abstract][Full Text] [Related]
7. PEGylated superparamagnetic iron oxide nanoparticles (SPIONs) ameliorate learning and memory deficit in a rat model of Alzheimer's disease: Potential participation of STIMs.
Sanati M; Aminyavari S; Khodagholi F; Hajipour MJ; Sadeghi P; Noruzi M; Moshtagh A; Behmadi H; Sharifzadeh M
Neurotoxicology; 2021 Jul; 85():145-159. PubMed ID: 34058247
[TBL] [Abstract][Full Text] [Related]
8. TREM1 facilitates microglial phagocytosis of amyloid beta.
Jiang T; Zhang YD; Gao Q; Zhou JS; Zhu XC; Lu H; Shi JQ; Tan L; Chen Q; Yu JT
Acta Neuropathol; 2016 Nov; 132(5):667-683. PubMed ID: 27670763
[TBL] [Abstract][Full Text] [Related]
9. Amyloid β oligomers in Alzheimer's disease pathogenesis, treatment, and diagnosis.
Viola KL; Klein WL
Acta Neuropathol; 2015 Feb; 129(2):183-206. PubMed ID: 25604547
[TBL] [Abstract][Full Text] [Related]
10. Fruitless Wolfberry-Sprout Extract Rescued Cognitive Deficits and Attenuated Neuropathology in Alzheimer's Disease Transgenic Mice.
Liu SY; Lu S; Yu XL; Yang SG; Liu W; Liu XM; Wang SW; Zhu J; Ji M; Liu DQ; Zhang ZP; Liu RT
Curr Alzheimer Res; 2018; 15(9):856-868. PubMed ID: 29623840
[TBL] [Abstract][Full Text] [Related]
11. Aβ-oligomer uptake and the resulting inflammatory response in adult human astrocytes are precluded by an anti-Aβ single chain variable fragment in combination with an apoE mimetic peptide.
Montoliu-Gaya L; Mulder SD; Herrebout MAC; Baayen JC; Villegas S; Veerhuis R
Mol Cell Neurosci; 2018 Jun; 89():49-59. PubMed ID: 29625180
[TBL] [Abstract][Full Text] [Related]
12. Decoding the synaptic dysfunction of bioactive human AD brain soluble Aβ to inspire novel therapeutic avenues for Alzheimer's disease.
Li S; Jin M; Liu L; Dang Y; Ostaszewski BL; Selkoe DJ
Acta Neuropathol Commun; 2018 Nov; 6(1):121. PubMed ID: 30409172
[TBL] [Abstract][Full Text] [Related]
13. A Novel scFv Anti-Aβ Antibody Reduces Pathological Impairments in APP/PS1 Transgenic Mice via Modulation of Inflammatory Cytokines and Aβ-related Enzymes.
Hu M; Zhang J; Yang J; Cao Y; Qi J
J Mol Neurosci; 2018 Sep; 66(1):1-9. PubMed ID: 30062438
[TBL] [Abstract][Full Text] [Related]
14. Peritoneal dialysis reduces amyloid-beta plasma levels in humans and attenuates Alzheimer-associated phenotypes in an APP/PS1 mouse model.
Jin WS; Shen LL; Bu XL; Zhang WW; Chen SH; Huang ZL; Xiong JX; Gao CY; Dong Z; He YN; Hu ZA; Zhou HD; Song W; Zhou XF; Wang YZ; Wang YJ
Acta Neuropathol; 2017 Aug; 134(2):207-220. PubMed ID: 28477083
[TBL] [Abstract][Full Text] [Related]
15. Microglia prevent beta-amyloid plaque formation in the early stage of an Alzheimer's disease mouse model with suppression of glymphatic clearance.
Feng W; Zhang Y; Wang Z; Xu H; Wu T; Marshall C; Gao J; Xiao M
Alzheimers Res Ther; 2020 Oct; 12(1):125. PubMed ID: 33008458
[TBL] [Abstract][Full Text] [Related]
16. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
Elife; 2020 Jun; 9():. PubMed ID: 32510331
[TBL] [Abstract][Full Text] [Related]
17. Resting microglia react to Aβ42 fibrils but do not detect oligomers or oligomer-induced neuronal damage.
Ferrera D; Mazzaro N; Canale C; Gasparini L
Neurobiol Aging; 2014 Nov; 35(11):2444-2457. PubMed ID: 24973120
[TBL] [Abstract][Full Text] [Related]
18. DW14006 as a direct AMPKα1 activator improves pathology of AD model mice by regulating microglial phagocytosis and neuroinflammation.
Lv J; Wang W; Zhu X; Xu X; Yan Q; Lu J; Shi X; Wang Z; Zhou J; Huang X; Wang J; Duan W; Shen X
Brain Behav Immun; 2020 Nov; 90():55-69. PubMed ID: 32739363
[TBL] [Abstract][Full Text] [Related]
19. Antibody-mediated phagocytosis of the amyloid beta-peptide in microglia is differentially modulated by C1q.
Webster SD; Galvan MD; Ferran E; Garzon-Rodriguez W; Glabe CG; Tenner AJ
J Immunol; 2001 Jun; 166(12):7496-503. PubMed ID: 11390503
[TBL] [Abstract][Full Text] [Related]
20. Scavenger Receptor-A deficiency impairs immune response of microglia and astrocytes potentiating Alzheimer's disease pathophysiology.
Cornejo F; Vruwink M; Metz C; Muñoz P; Salgado N; Poblete J; Andrés ME; Eugenín J; von Bernhardi R
Brain Behav Immun; 2018 Mar; 69():336-350. PubMed ID: 29246456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
